- Investing Ideas
- Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Chinese Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
3
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
3 companies
Shanghai Allist Pharmaceuticals
Market Cap: CN¥56.6b
A pharmaceutical company, engages in the research and development of tumor-targeted drugs in China in internationally.
688578
CN¥130.87
7D
37.6%
1Y
38.3%
Sunshine Guojian Pharmaceutical (Shanghai)
Market Cap: CN¥52.4b
A biopharmaceutical company, engages in the research and development, production, and sale of antibody drugs.
688336
CN¥59.16
7D
32.9%
1Y
56.3%
Shenyang Xingqi PharmaceuticalLtd
Market Cap: CN¥15.2b
Engages in the research, development, production, and sale of ophthalmic drugs in the People’s Republic of China.
300573
CN¥42.10
7D
4.2%
1Y
16.9%